The data on global hospital discharges for chronic obstructive pulmonary disease (COPD) and bronchiectasis highlights Germany as the leader with a significant 317.94 thousand discharges in 2024, showing a slight increase from 2023 by 1.95%. Other countries depict negative year-on-year trends, with South Korea down by 1.32%, Hungary by 1.71%, and Mexico by 1.77%. Switzerland and Norway, conversely, exhibit modest growth with a 1.89% and 1.45% increase, respectively. Iceland records the most significant decline at 4.1%.
Future trends to watch include potential healthcare system enhancements or policy changes that could impact discharge rates. The variations suggest shifts in healthcare strategies, with countries like Germany likely focusing on efficiency, while declines in other regions may indicate changing patterns in disease management or prevention efforts. Increasing aging populations and environmental factors are also critical elements that may influence future discharge rates for COPD and bronchiectasis globally.
Top countries in Hospital Discharges for Chronic Obstructive Pulmonary Disease and Bronchiectasis by Country
| # | 10 Countries | Units (Hospital Discharges) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 317,940 | 2023 | +8.71% | +1.95% | View data |
| 2 | 2 South Korea | 70,760 | 2023 | +11.26% | -1.32% | View data |
| 3 | 3 Hungary | 28,570 | 2023 | +8.13% | -1.71% | View data |
| 4 | 4 Mexico | 26,690 | 2023 | +7.74% | -1.77% | View data |
| 5 | 5 Austria | 23,580 | 2023 | +3.72% | -1.84% | View data |
| 6 | 6 Czech Republic | 16,940 | 2023 | +3.67% | -0.62% | View data |
| 7 | 7 Sweden | 16,220 | 2023 | +3.7% | -0.23% | View data |
| 8 | 8 Switzerland | 13,840 | 2023 | +8.97% | +1.89% | View data |
| 9 | 9 Chile | 13,200 | 2023 | +8.19% | -2.52% | View data |
| 10 | 10 Norway | 12,300 | 2023 | +5.48% | +1.45% | View data |
